224 related articles for article (PubMed ID: 35606803)
21. Characterising social contacts under COVID-19 control measures in Africa.
Dobreva Z; Gimma A; Rohan H; Djoudalbaye B; Tshangela A; Jarvis CI; van Zandvoort K; Quaife M
BMC Med; 2022 Oct; 20(1):344. PubMed ID: 36221094
[TBL] [Abstract][Full Text] [Related]
22. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
24. The Efficacy of a Brief, Altruism-Eliciting Video Intervention in Enhancing COVID-19 Vaccination Intentions Among a Population-Based Sample of Younger Adults: Randomized Controlled Trial.
Zhu P; Tatar O; Griffin-Mathieu G; Perez S; Haward B; Zimet G; Tunis M; Dubé È; Rosberger Z
JMIR Public Health Surveill; 2022 May; 8(5):e37328. PubMed ID: 35544437
[TBL] [Abstract][Full Text] [Related]
25. Who should be prioritized for COVID-19 vaccination in China? A descriptive study.
Yang J; Zheng W; Shi H; Yan X; Dong K; You Q; Zhong G; Gong H; Chen Z; Jit M; Viboud C; Ajelli M; Yu H
BMC Med; 2021 Feb; 19(1):45. PubMed ID: 33563270
[TBL] [Abstract][Full Text] [Related]
26. Social contact patterns during the COVID-19 pandemic in 21 European countries - evidence from a two-year study.
Wong KLM; Gimma A; Coletti P; ; Faes C; Beutels P; Hens N; Jaeger VK; Karch A; Johnson H; Edmunds W; Jarvis CI
BMC Infect Dis; 2023 Apr; 23(1):268. PubMed ID: 37101123
[TBL] [Abstract][Full Text] [Related]
27. Changes in social contacts in England during the COVID-19 pandemic between March 2020 and March 2021 as measured by the CoMix survey: A repeated cross-sectional study.
Gimma A; Munday JD; Wong KLM; Coletti P; van Zandvoort K; Prem K; ; Klepac P; Rubin GJ; Funk S; Edmunds WJ; Jarvis CI
PLoS Med; 2022 Mar; 19(3):e1003907. PubMed ID: 35231023
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
29. Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine.
Zaprutko T; Kremin Y; Michalak M; Bernatoniene J; Zaprutko L; Hudz N; Stolecka A; Cynar J; Niewczas K; Sprawka J; Skorupska P; Wróbel J; Ratajczak P; Kopciuch D; Paczkowska A; Kus K; Hromovyk B
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206232
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 Case Investigation and Contact Tracing in Central Washington State, June-July 2020.
Miller JS; Bonacci RA; Lash RR; Moonan PK; Houck P; Van Meter JJ; Butler M; Everson T; Morrison B; Sixberry M; Person A; Oeltmann JE
J Community Health; 2021 Oct; 46(5):918-921. PubMed ID: 33689116
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
[TBL] [Abstract][Full Text] [Related]
32. COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.
Barchuk A; Skougarevskiy D; Kouprianov A; Shirokov D; Dudkina O; Tursun-Zade R; Sergeeva M; Tychkova V; Komissarov A; Zheltukhina A; Lioznov D; Isaev A; Pomerantseva E; Zhikrivetskaya S; Sofronova Y; Blagodatskikh K; Titaev K; Barabanova L; Danilenko D
PLoS One; 2022; 17(6):e0266945. PubMed ID: 35704649
[TBL] [Abstract][Full Text] [Related]
33. Social Media Engagement and Influenza Vaccination During the COVID-19 Pandemic: Cross-sectional Survey Study.
Benis A; Khodos A; Ran S; Levner E; Ashkenazi S
J Med Internet Res; 2021 Mar; 23(3):e25977. PubMed ID: 33651709
[TBL] [Abstract][Full Text] [Related]
34. Age-Varying Susceptibility to the Delta Variant (B.1.617.2) of SARS-CoV-2.
Chun JY; Jeong H; Kim Y
JAMA Netw Open; 2022 Mar; 5(3):e223064. PubMed ID: 35302625
[TBL] [Abstract][Full Text] [Related]
35. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
[TBL] [Abstract][Full Text] [Related]
36. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
37. Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults.
Tang X; Sharma A; Pasic M; Brown P; Colwill K; Gelband H; Birnboim HC; Nagelkerke N; Bogoch II; Bansal A; Newcombe L; Slater J; Rodriguez PS; Huang G; Fu SH; Meh C; Wu DC; Kaul R; Langlois MA; Morawski E; Hollander A; Eliopoulos D; Aloi B; Lam T; Abe KT; Rathod B; Fazel-Zarandi M; Wang J; Iskilova M; Pasculescu A; Caldwell L; Barrios-Rodiles M; Mohammed-Ali Z; Vas N; Santhanam DR; Cho ER; Qu K; Jha S; Jha V; Suraweera W; Malhotra V; Mastali K; Wen R; Sinha S; Reid A; Gingras AC; Chakraborty P; Slutsky AS; Jha P;
JAMA Netw Open; 2022 Feb; 5(2):e2146798. PubMed ID: 35171263
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
39. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study.
Tzur Bitan D; Kridin K; Cohen AD; Weinstein O
Lancet Psychiatry; 2021 Oct; 8(10):901-908. PubMed ID: 34364406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
